drugset / Trial / NCT04806919

Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone

NCT04806919

Phase 3 Completed 87 enrolled University Hospital, Ghent
RandomizedParallel-groupOpen-labelTreatment

Summary

The study aims to evaluate the effect of an increased dose of vaginal progesterone supplementation on the incidence of ongoing pregnancy for patients with a suboptimal serum progesterone level (defined as \< 10 mcg/l) on the day of blastocyst transfer.

Timeline

Start
2021-04-02
Primary completion
2025-02-28
Completion
2025-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 400 mg Other